1. Home
  2. MRVI vs SEAT Comparison

MRVI vs SEAT Comparison

Compare MRVI & SEAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • SEAT
  • Stock Information
  • Founded
  • MRVI 2014
  • SEAT 2001
  • Country
  • MRVI United States
  • SEAT United States
  • Employees
  • MRVI N/A
  • SEAT N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • SEAT Industrial Machinery/Components
  • Sector
  • MRVI Health Care
  • SEAT Industrials
  • Exchange
  • MRVI Nasdaq
  • SEAT Nasdaq
  • Market Cap
  • MRVI 312.4M
  • SEAT 366.2M
  • IPO Year
  • MRVI 2020
  • SEAT N/A
  • Fundamental
  • Price
  • MRVI $2.20
  • SEAT $16.76
  • Analyst Decision
  • MRVI Hold
  • SEAT Buy
  • Analyst Count
  • MRVI 10
  • SEAT 11
  • Target Price
  • MRVI $6.84
  • SEAT $81.45
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • SEAT 226.4K
  • Earning Date
  • MRVI 08-11-2025
  • SEAT 08-05-2025
  • Dividend Yield
  • MRVI N/A
  • SEAT N/A
  • EPS Growth
  • MRVI N/A
  • SEAT N/A
  • EPS
  • MRVI N/A
  • SEAT N/A
  • Revenue
  • MRVI $241,856,000.00
  • SEAT $694,007,000.00
  • Revenue This Year
  • MRVI N/A
  • SEAT N/A
  • Revenue Next Year
  • MRVI $10.70
  • SEAT $4.42
  • P/E Ratio
  • MRVI N/A
  • SEAT N/A
  • Revenue Growth
  • MRVI N/A
  • SEAT N/A
  • 52 Week Low
  • MRVI $1.67
  • SEAT $15.27
  • 52 Week High
  • MRVI $9.95
  • SEAT $100.00
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 42.78
  • SEAT 27.29
  • Support Level
  • MRVI $1.99
  • SEAT $19.58
  • Resistance Level
  • MRVI $2.40
  • SEAT $35.00
  • Average True Range (ATR)
  • MRVI 0.16
  • SEAT 4.16
  • MACD
  • MRVI -0.06
  • SEAT -1.67
  • Stochastic Oscillator
  • MRVI 25.15
  • SEAT 6.62

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About SEAT Vivid Seats Inc.

Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.

Share on Social Networks: